Treatment and surveillance for non-muscle-invasive bladder cancer in China: an evidence-based clinical practice guideline (2018 simplified version)_Chinese Journal of Evidence-Based Medicine

Authors：

 Urological Association, Chinese Research Hospital Association (CRHA); Urological Health Promotive Association, China International Exchange and Promotive Association for Medical and Health Care (CPAM); Evidence-Based Medicine Association, China International Exchange and Promotive Association for Medical and Health Care (CPAM); The Project Team for Minimally Invasive Plasma Kinetic System and Cloud Planning Solution, The National Key Research and Development Program of China

Corresponding author：

Urological Association, Chinese Research Hospital Association (CRHA); Urological Health Promotive Association, China International Exchange and Promotive Association for Medical and Health Care (CPAM); Evidence-Based Medicine Association, China International Exchange and Promotive Association for Medical and Health Care (CPAM); The Project Team for Minimally Invasive Plasma Kinetic System and Cloud Planning Solution, The National Key Research and Development Program of China, Email: wangxinghuan1965@163.com; hedl@xjtu.edu.cn

Keywords：

Non-muscle-invasive bladder cancer; Transurethral resection of bladder tumor; Bacillus Calmette-Guérin; Treatment surveillance; Evidence-based clinical practice guideline

DOI：

10.7507/1672-2531.201812031

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： Urological Association, Chinese Research Hospital Association (CRHA); Urological Health Promotive Association, China International Exchange and Promotive Association for Medical and Health Care (CPAM); Evidence-Based Medicine Association, China International Exchange and Promotive Association for Medical and Health Care (CPAM); The Project Team for Minimally Invasive Plasma Kinetic System and Cloud Planning Solution, The National Key Research and Development Program of China. Treatment and surveillance for non-muscle-invasive bladder cancer in China: an evidence-based clinical practice guideline (2018 simplified version). Chinese Journal of Evidence-Based Medicine, 2018, 18(12): 1267-1272. doi: 10.7507/1672-2531.201812031 Copy

1.	靳英辉, 曾宪涛, 刘同族, 等. 非肌层浸润性膀胱癌治疗与监测循证临床实践指南研究方案. 中国研究型医院, 2018, 5(3): 42-51.
2.	中国研究型医院学会泌尿外科学专业委员会, 中国医疗保健国际交流促进会泌尿健康促进分会, 中国医疗保健国际交流促进会循证医学分会, 等. 中国良性前列腺增生症经尿道等离子双极电切术治疗指南 (2018 标准版). 中华医学杂志, 2018, 98(20): 1549-1560.
3.	中国研究型医院学会泌尿外科学专业委员会, 中国医疗保健国际交流促进会泌尿健康促进分会, 中国医疗保健国际交流促进会循证医学分会, 等. 中国良性前列腺增生症经尿道等离子双极电切术治疗指南 (2018 简化版). 中国循证医学杂志, 2018, 88(6): 543-546.
4.	Sobin DH, Witteking Ch, eds. TNM Classification of Malignant tumors, 6th ed. New York: Wiley-Liss, 2002.
5.	Sobin LH, Gospodariwicz M, Wittekind C, eds. TNM classification of malignant tumors. UICC International Union against cancer, 7th ed. New York: Wiley-Blackwell, 2009.
6.	Sauter G, Algaba F, Amin M, et al. Tumour of urinary system: non-invasive urothelial neoplasia. In Eble JN, Sauter G, Epstein JI, Sesterhenn, et al. WHO classification of classification of tumour of urinary system and male genital organs. Lyon: IARCC Press, 2004.
7.	Epstein JI, Amin MB, Reuter VR, et al. The World Health Organization/ International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol, 1998, 22: 1435-1448.
8.	Kurth KH, Denis L, Bouffioux C, et al. Factors affecting recurrence and progression in superficial bladder cancer. Eur J Cancer, 1995, 31A: 1840-1846.
9.	Parmar MKB, Freedman LS, Hargreave TB, et al. Prognostic factors for recurrence and follow-up policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer. J Urol, 1989, 142: 284-288.
10.	Witjes JA, Kiemenig La LM, Oosterhof GON, et al. Prognostic factors in superficial bladder cancer. Eur Urol, 1992, 21: 89-97.
11.	Allard P, Bernard P, Fradet Y, et al. The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index. Br J Urol, 1998, 81: 692-698.
12.	Fuji Y, Fukui I, Kihara K, et al. Significance of bladder neck involvement on progression in superficial bladder cancer. Eur Urol, 1998, 33: 464-468.

1. 靳英辉, 曾宪涛, 刘同族, 等. 非肌层浸润性膀胱癌治疗与监测循证临床实践指南研究方案. 中国研究型医院, 2018, 5(3): 42-51.
2. 中国研究型医院学会泌尿外科学专业委员会, 中国医疗保健国际交流促进会泌尿健康促进分会, 中国医疗保健国际交流促进会循证医学分会, 等. 中国良性前列腺增生症经尿道等离子双极电切术治疗指南 (2018 标准版). 中华医学杂志, 2018, 98(20): 1549-1560.
3. 中国研究型医院学会泌尿外科学专业委员会, 中国医疗保健国际交流促进会泌尿健康促进分会, 中国医疗保健国际交流促进会循证医学分会, 等. 中国良性前列腺增生症经尿道等离子双极电切术治疗指南 (2018 简化版). 中国循证医学杂志, 2018, 88(6): 543-546.
4. Sobin DH, Witteking Ch, eds. TNM Classification of Malignant tumors, 6th ed. New York: Wiley-Liss, 2002.
5. Sobin LH, Gospodariwicz M, Wittekind C, eds. TNM classification of malignant tumors. UICC International Union against cancer, 7th ed. New York: Wiley-Blackwell, 2009.
6. Sauter G, Algaba F, Amin M, et al. Tumour of urinary system: non-invasive urothelial neoplasia. In Eble JN, Sauter G, Epstein JI, Sesterhenn, et al. WHO classification of classification of tumour of urinary system and male genital organs. Lyon: IARCC Press, 2004.
7. Epstein JI, Amin MB, Reuter VR, et al. The World Health Organization/ International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol, 1998, 22: 1435-1448.
8. Kurth KH, Denis L, Bouffioux C, et al. Factors affecting recurrence and progression in superficial bladder cancer. Eur J Cancer, 1995, 31A: 1840-1846.
9. Parmar MKB, Freedman LS, Hargreave TB, et al. Prognostic factors for recurrence and follow-up policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer. J Urol, 1989, 142: 284-288.
10. Witjes JA, Kiemenig La LM, Oosterhof GON, et al. Prognostic factors in superficial bladder cancer. Eur Urol, 1992, 21: 89-97.
11. Allard P, Bernard P, Fradet Y, et al. The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index. Br J Urol, 1998, 81: 692-698.
12. Fuji Y, Fukui I, Kihara K, et al. Significance of bladder neck involvement on progression in superficial bladder cancer. Eur Urol, 1998, 33: 464-468.

Next Article
The interpretation of clinical practice guideline for abdominal aortic aneurysm of American Society for Vascular Surgery in 2018

Chinese Journal of Evidence-Based Medicine

Treatment and surveillance for non-muscle-invasive bladder cancer in China: an evidence-based clinical practice guideline (2018 simplified version)

Abstract Full text Figures/Tables Video References Cited by

Next Article

Format

Content